Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACkER trial of triple therapy versus LABA/LAMA in COPD patients with asthma-like characteristics
2023-508300-37-00Phase 4Completed
- Sponsor
- General Practitioners Research Institute
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of beclomethasone dipropionate, formoterol, glycopyrronium, tiotropium, olodaterol and 4 more in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by General Practitioners Research Institute. Started Oct 2023; status: completed.
02
Drugs
beclomethasone dipropionateformoterolglycopyrroniumtiotropiumolodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2023-508300-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508300-37-00.